The study included: 67,769 people with type 2 diabetes and 17,604 people with overweight or obesity and cardiovascular disease but without diabetes
However, an increase in gastrointestinal adverse events, diarrhea, hypoglycemia, nausea, neoplasm, treatment-emergent adverse events, pancreatic enzymes, diabetic retinopathy complications, and pancreatic cancer was observed to accompany the treatment using semaglutide
Patients who start GLP treatment typically begin with a low dose, which is gradually increased over several weeks to minimize any associated side effects
Absaloutely gobsmacked at how fast Ive got a dark glowy tan
It's also critical to realize when a "plateau" isn't a plateau